Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Active, not recruiting · NCT02932280 · Registry updated 2025-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, central nervous system cancer, disease, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-05 | NCT02932280 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alberta Children's Hospital | Calgary | Canada | 70 |
| Arkansas Children's Hospital | Little Rock | United States | 1 |
| Arnold Palmer Hospital for Children | Orlando | United States | 79 |
| Huntsman Cancer Institue | Salt Lake City | United States | 2 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Pennsylvania State Hershey Children's Hospital | Hershey | United States | 1 |
| Phoenix Children's Hospital | Phoenix | United States | 95 |
| Stanford University School of Medicine and Stanford Cancer Institute | Palo Alto | United States | 1 |
| University of Texas | San Antonio | United States | 1 |